Clinical Trial Update: Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia (FAIRY) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial FAIRY evaluating ferric carboxymaltose (Ferinject) for acute isovolemic anemia in gastrectomy patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Ferinject (ferric carboxymaltose)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Anemia | Phase 3 | Status: COMPLETED